Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MEILAN K HAN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1457433369
CMS profile
111636
Location
ANN ARBOR, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$157,625.77

85 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $86,461.17 31
GlaxoSmithKline, LLC. $20,919.33 9
AstraZeneca Pharmaceuticals LP $17,816.79 24
AstraZeneca AB $11,555.25 7
Regeneron Pharmaceuticals, Inc. $7,123.25 5
Amgen Inc. $5,115.50 2
AstraZeneca UK Limited $2,685.00 1
Merck Sharp & Dohme LLC $2,441.25 1
F. Hoffmann-La Roche AG $1,849.00 2
Teva Pharmaceuticals USA, Inc. $1,659.23 3

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

85 matching records · $157,625.77 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 85 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 85.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $36.7212/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214217 CMS
GENZYME CORPORATION $8.1612/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214219 CMS
GENZYME CORPORATION $21.6412/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214221 CMS
GENZYME CORPORATION $205.4612/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214223 CMS
GENZYME CORPORATION $10,787.2512/09/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214237 CMS
GENZYME CORPORATION $439.9112/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214239 CMS
GENZYME CORPORATION $320.9812/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214241 CMS
GENZYME CORPORATION $9,986.6812/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214243 CMS
Merck Sharp & Dohme LLC $2,441.2512/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048819345 CMS
GlaxoSmithKline, LLC. $2,600.0011/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002298297 CMS
Teva Pharmaceuticals USA, Inc. $421.7111/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056830243 CMS
AstraZeneca AB $537.0010/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017067399 CMS
Teva Pharmaceuticals USA, Inc. $970.2610/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056830245 CMS
GENZYME CORPORATION $4,731.2509/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214245 CMS
GENZYME CORPORATION $120.0009/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912695 CMS
GENZYME CORPORATION $14,074.0009/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912699 CMS
GENZYME CORPORATION $338.3009/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214213 CMS
GENZYME CORPORATION $10,937.7509/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214215 CMS
GlaxoSmithKline, LLC. $59.0809/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061463890 CMS
GlaxoSmithKline, LLC. $1,004.5409/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061464236 CMS
GENZYME CORPORATION $325.6209/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912645 CMS
GENZYME CORPORATION $559.3809/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912649 CMS
GENZYME CORPORATION $762.5909/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912653 CMS
GENZYME CORPORATION $11.1009/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912657 CMS
GENZYME CORPORATION $52.7209/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912661 CMS
GENZYME CORPORATION $120.0009/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912663 CMS
GENZYME CORPORATION $10,030.2509/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049912667 CMS
GENZYME CORPORATION $63.8209/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214211 CMS
GENZYME CORPORATION $10,030.2509/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214225 CMS
GENZYME CORPORATION $120.0009/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214227 CMS
GENZYME CORPORATION $762.5909/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214229 CMS
GENZYME CORPORATION $559.3809/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214231 CMS
GENZYME CORPORATION $325.6209/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214233 CMS
AstraZeneca Pharmaceuticals LP $9,397.5009/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016268555 CMS
AstraZeneca AB $6,444.0008/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017003835 CMS
AstraZeneca AB $144.0008/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017075753 CMS
GENZYME CORPORATION $4,540.0008/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061214247 CMS
AstraZeneca Pharmaceuticals LP $240.0008/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014280077 CMS
AstraZeneca Pharmaceuticals LP $49.9907/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011904665 CMS
AstraZeneca Pharmaceuticals LP $78.7907/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014813169 CMS
AstraZeneca Pharmaceuticals LP $259.5007/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011262219 CMS
AstraZeneca Pharmaceuticals LP $134.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011518109 CMS
AstraZeneca Pharmaceuticals LP $59.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011645795 CMS
AstraZeneca Pharmaceuticals LP $49.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015090203 CMS
AstraZeneca Pharmaceuticals LP $48.1507/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015956153 CMS
Regeneron Pharmaceuticals, Inc. $1,390.0007/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000014549 CMS
Regeneron Pharmaceuticals, Inc. $2,780.0007/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000014559 CMS
Regeneron Pharmaceuticals, Inc. $2,780.0007/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000014569 CMS
AstraZeneca AB $1,342.5007/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017071199 CMS
AstraZeneca Pharmaceuticals LP $259.5007/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011785341 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $125,581.65 138
PY2020 $90,827.31 26
PY2021 $81,734.00 28
PY2022 $43,546.33 14
PY2023 $157,625.77 85
PY2024 $152,233.29 85
PY2025 $127,322.32 74

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MEILAN K HAN, NPI 1457433369. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1457433369.
APA 7
IndustryPayments. (2026). MEILAN K HAN, NPI 1457433369 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1457433369
Bluebook
MEILAN K HAN, NPI 1457433369, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1457433369.

Source: Centers for Medicare & Medicaid Services, Open Payments.